nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acknowledgement of reviewers 2021
|
|
|
|
90 |
1 |
p. 105-107 |
artikel |
2 |
A phase Ib study of Oraxol (oral paclitaxel and encequidar) in patients with advanced malignancies
|
Ma, Wen Wee |
|
|
90 |
1 |
p. 7-17 |
artikel |
3 |
A phase I/II study of 10-min dosing of bendamustine hydrochloride (rapid infusion formulation) in patients with previously untreated indolent B-cell non-Hodgkin lymphoma, mantle cell lymphoma, or relapsed/refractory diffuse large B-cell lymphoma in Japan
|
Ishizawa, Kenichi |
|
|
90 |
1 |
p. 83-95 |
artikel |
4 |
Aprepitant, fosaprepitant and risk of ifosfamide-induced neurotoxicity: a systematic review
|
Vazirian, Fatemeh |
|
|
90 |
1 |
p. 1-6 |
artikel |
5 |
Development of a population pharmacokinetic/pharmacodynamic model for various oral paclitaxel formulations co-administered with ritonavir and thrombospondin-1 based on data from early phase clinical studies
|
van Eijk, Maarten |
|
|
90 |
1 |
p. 71-82 |
artikel |
6 |
Efficacy and toxicity of vemurafenib and cobimetinib in relation to plasma concentrations, after administration via feeding tube in patients with BRAF-mutated thyroid cancer: a case series and review of literature
|
van Berge Henegouwen, J. M. |
|
|
90 |
1 |
p. 97-104 |
artikel |
7 |
Evaluation of drug–drug interactions between midostaurin and strong CYP3A4 inhibitors in patients with FLT-3-mutated acute myeloid leukemia (AML)
|
Sechaud, Romain |
|
|
90 |
1 |
p. 19-27 |
artikel |
8 |
Exposure–response analyses for the MET inhibitor tepotinib including patients in the pivotal VISION trial: support for dosage recommendations
|
Xiong, Wenyuan |
|
|
90 |
1 |
p. 53-69 |
artikel |
9 |
Impact of pharmacogenetics on variability in exposure to oral vinorelbine among pediatric patients: a model‐based population pharmacokinetic analysis
|
Hamimed, Mourad |
|
|
90 |
1 |
p. 29-44 |
artikel |
10 |
The comparison of plasma arsenic concentration and urinary arsenic excretion during treatment with Realgar-Indigo naturalis formula and arsenic trioxide in children with acute promyelocytic leukemia
|
Liao, Liu-Hua |
|
|
90 |
1 |
p. 45-52 |
artikel |